PT  - JOURNAL ARTICLE
AU  - Carrillo, Angeles
AU  - Manzur, María Jimena
AU  - Ayub, Maximiliano Juri
TI  - Saliva direct PCR protocol for HLA-DQB1*02 genotyping
AID  - 10.1101/2023.10.25.23297535
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.10.25.23297535
4099  - http://medrxiv.org/content/early/2023/12/07/2023.10.25.23297535.short
4100  - http://medrxiv.org/content/early/2023/12/07/2023.10.25.23297535.full
AB  - Celiac Disease (CD) is an immune disorder that is triggered by gluten ingestion in genetically predisposed individuals. The HLA-DQB1*02 allele is the main predisposing genetic factor, and a candidate for first-line genotyping screening. We designed and validated a simple, DNA purification-free PCR protocol directly from crude saliva, enabling the detection of the DQB1*02 allele. This assay also distinguishes homozygous from heterozygous carriers. We propose this method for use in mass screening and/or epidemiological studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by National University of San Luis Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Comite Provincial de Etica de la Investigacion en Salud. Ministerio de Salud de la Provincia de San Luis. San Luis, ArgentinaI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript